Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
40%
Ph phase_3
3
60%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (40.0%)
Phase 33 (60.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_3

A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

NCT00395070
completedphase_2

Phase II Trial of Allovectin-7® for Metastatic Melanoma

NCT00044356
completedphase_2

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00003646
completedphase_3

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00003647
completedphase_3

Phase II Trial of Allovectin-7® for Head and Neck Cancer

NCT00050388

Clinical Trials (5)

Showing 5 of 5 trials
NCT00395070Phase 3

A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

Completed
NCT00044356Phase 2

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Completed
NCT00003646Phase 2

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Completed
NCT00003647Phase 3

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Completed
NCT00050388Phase 3

Phase II Trial of Allovectin-7® for Head and Neck Cancer

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5